# Phase 4 Summary — Disease Risk Prediction

## Architecture Changes

```
USE_RISK_MODEL=0 / USE_DISEASE_RISK_MODEL=0
  → UnavailableRiskPredictor

USE_RISK_MODEL=1 (or disease alias)
  → FallbackRiskPredictor(MLDiseaseRiskPredictor, Unavailable)
  → DiseaseRiskEngine: per-disease binary classifiers
```

Backends: **XGBoost** → LightGBM → sklearn HistGB · baseline logistic available.

## Files Created

- `models/risk_prediction/` full package  
- `tests/phase4/`  
- datasets synthetic + licensing  
- `docs/benchmark_phase4.md`, validation, phase4-summary  

## Files Modified

- adapters/registry/feature_flags  
- `RiskPredictionResult` optional `conditions`  
- docs / `.env.example`  

## Datasets

Synthetic longitudinal biomarkers shipped. MIMIC/NHANES/eICU/UCI optional external env paths only.

## Feature Engineering

Lab synonym map, latest-value collapse, AST/ALT & TC/HDL ratios, missing fraction, median impute.

## Training / Evaluation

`train.py` / `evaluate.py` config-driven; artefacts under `models/risk_prediction/artifacts/`.

## Benchmarks

ML macro ROC-AUC **0.984** vs rules **0.962** on synthetic eval (XGBoost).

## Validation

**PASS** — `validation/model4-validation.md`

## Documentation Updated

CONFIG, CHANGELOG, MODEL_REGISTRY, ROADMAP, ML_ARCHITECTURE, TRAINING, migration plan, model card, evaluation notes.

## Known Limitations

- Synthetic labels ≠ clinical truth  
- Registry-only surface (no FE)  
- Must keep non-diagnostic language in all UX if exposed later  

## Repository Health Score

**8.5 / 10**

## Definition of Done

All criteria met → **PHASE 4 COMPLETE**  
**Do not begin Phase 5.**
